Anteris Technologies Ltd
ASX:AVR

Watchlist Manager
Anteris Technologies Ltd Logo
Anteris Technologies Ltd
ASX:AVR
Watchlist
Price: 9.02 AUD -4.95% Market Closed
Market Cap: 324.2m AUD
Have any thoughts about
Anteris Technologies Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one AVR stock under the Base Case scenario is 0.52 AUD. Compared to the current market price of 9.02 AUD, Anteris Technologies Ltd is Overvalued by 94%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AVR Relative Value
Base Case
0.52 AUD
Overvaluation 94%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

45.4
P/S
P/S
Price to Sales
45.4
vs History
44
vs Industry
5
Median 3Y
92.2
Median 5Y
62.5
Industry
2.3
Forward
51
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-14.7
Median 5Y
-17.9
Industry
23
Forward
-4.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-17
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-15.8
Median 5Y
-15.5
Industry
20
More Details
57.1
P/B
P/B
Price to Book Value
57.1
vs History
6
vs Industry
6
Median 3Y
36.6
Median 5Y
33.7
Industry
2.2
More Details
44.1
EV/S
EV/S
Enterprise Value to Sales
44.1
vs History
44
vs Industry
5
Median 3Y
90.9
Median 5Y
60.3
Industry
2.4
Forward
49.6
More Details
64.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
64.5
vs History
42
vs Industry
5
Median 3Y
120.3
Median 5Y
76.9
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-14.1
Median 5Y
-13.8
Industry
12.9
Forward
-2.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-14.1
Median 5Y
-13.8
Industry
17.4
Forward
-2.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-17.4
Median 5Y
-16.6
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-16.2
Median 5Y
-15.5
Industry
18.2
More Details
178.5
EV/IC
EV/IC
Enterprise Value to IC
178.5
vs History
9
vs Industry
1
Median 3Y
189.3
Median 5Y
139.8
Industry
1.9
More Details

Multiples Across Competitors

AVR Competitors Multiples
Anteris Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Anteris Technologies Ltd
ASX:AVR
324.2m AUD 45.4 -3.7 -3.4 -3.4
JP
Hoya Corp
TSE:7741
7T JPY 8.5 35.6 23.5 28.3
CH
Alcon AG
SIX:ALC
37.9B CHF 4.3 35.8 17.6 34.1
DK
Coloplast A/S
CSE:COLO B
178.7B DKK 6.6 35.4 22.8 26.8
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.4 22.1
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 199.1 -55.7 -85.7 -80.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
49B CNY 11.1 26.5 23 23
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.6 12
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 56
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.5 264.6 462.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.6 23.7 38.9
P/E Multiple
Earnings Growth PEG
AU
Anteris Technologies Ltd
ASX:AVR
Average P/E: 33.8
Negative Multiple: -3.7 		N/A N/A
JP
Hoya Corp
TSE:7741
35.6
15%
2.4
CH
Alcon AG
SIX:ALC
35.8
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.4
15%
2.4
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.7 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.5
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.5
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.6
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Anteris Technologies Ltd
ASX:AVR
Average EV/EBITDA: 46.8
Negative Multiple: -3.4 		N/A N/A
JP
Hoya Corp
TSE:7741
23.5
15%
1.6
CH
Alcon AG
SIX:ALC
17.6
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.8
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.4
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.7 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.6
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.6
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.7
22%
1.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Anteris Technologies Ltd
ASX:AVR
Average EV/EBIT: 78.1
Negative Multiple: -3.4 		N/A N/A
JP
Hoya Corp
TSE:7741
28.3
N/A N/A
CH
Alcon AG
SIX:ALC
34.1
27%
1.3
DK
Coloplast A/S
CSE:COLO B
26.8
12%
2.2
US
Align Technology Inc
NASDAQ:ALGN
22.1
17%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -80.8 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23
23%
1
US
Lantheus Holdings Inc
NASDAQ:LNTH
12
12%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
56
56%
1
UK
ConvaTec Group PLC
LSE:CTEC
462.2
25%
18.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
38.9
36%
1.1

See Also

Summary
AVR intrinsic value, competitors valuation, and company profile.
DCF Valuation
AVR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AVR stock valuation using valuation multiples.
Wall Street Estimates
AVR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AVR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.